Equity Research, Broker Reports, and media content on Silence Therapeutics

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Silence Therapeutics
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Silence Therapeutics

Company Profile

  • Personnel
  • David Horn Solomon, CEO
  • Rob Quinn, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Silence Therapeutics. We currently have 28 research reports from 4 professional analysts.

  • Open: 468p
  • Range Today: 461/468p
  • 52 Week: 73.0/515p
  • Daily Volume: 20.3k
  • Daily Liquidity: (0.02%)
  • # Shares: 82.8m
  • Market Cap: £387.6m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
02Jul20 10:50 RNS Holding(s) in Company
02Jul20 07:00 RNS Circular and notice of general meeting
30Jun20 12:39 RNS Holding(s) in Company
29Jun20 16:55 RNS Holding(s) in Company
23Jun20 07:00 RNS Business Update
23Jun20 07:00 RNS Submission of Registration Statement to the US SEC
10Jun20 17:58 RNS Holding(s) in Company
  • Frequency of research reports


  • Research reports on

    Silence Therapeutics

  • Providers covering

    Silence Therapeutics